Hydroxyethyl starch (HES) solutions for infusion - Important Safety Information from Frasenius Kabi Limited as approved by the HPRA

Notice type: 3rd Party Publications

Date: 06/09/2018

Important Safety Information communication from Frasenius Kabi Limited on new measures to reinforce existing restrictions due to increased risk of renal dysfunction and mortality in critically ill or septic patients.

Important Safety Information - Hydroxyethyl starch (HES)